Dr Reddy’s Laboratories, third largest Indian pharma major after Sun Pharmaceutical and Aurobindo Pharma, has posted net profit of Rs. 1,337 crore during the second quarter ended September 2025 ...
Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback